APA (7th ed.) Citation

Wang, X., Li, T., Slebos, R. J. C., Chaudhary, R., Guevara-Patino, J. A., Bonomi, M., . . . Chung, C. H. (2025). Clinical significance of peripheral T-cell repertoire in head and neck squamous cell carcinoma treated with cetuximab and nivolumab. Cancer Immunology, Immunotherapy, 74(4), 1. https://doi.org/10.1007/s00262-025-03993-6

Chicago Style (17th ed.) Citation

Wang, Xuefeng, Tingyi Li, Robbert J. C. Slebos, Ritu Chaudhary, Jose A. Guevara-Patino, Marcelo Bonomi, Nabil F. Saba, and Christine H. Chung. "Clinical Significance of Peripheral T-cell Repertoire in Head and Neck Squamous Cell Carcinoma Treated with Cetuximab and Nivolumab." Cancer Immunology, Immunotherapy 74, no. 4 (2025): 1. https://doi.org/10.1007/s00262-025-03993-6.

MLA (9th ed.) Citation

Wang, Xuefeng, et al. "Clinical Significance of Peripheral T-cell Repertoire in Head and Neck Squamous Cell Carcinoma Treated with Cetuximab and Nivolumab." Cancer Immunology, Immunotherapy, vol. 74, no. 4, 2025, p. 1, https://doi.org/10.1007/s00262-025-03993-6.